C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2006
12/13/2006	EP1731518A1 Cyclic amine compound and pest control agent
12/13/2006	EP1731511A1 BicyclischeI heterocycles, medicaments containing these compounds, their use and methods for the production thereof
12/13/2006	EP1730165A1 Inhibitors of hepatitis c virus ns3 protease
12/13/2006	EP1730152A2 Tetrahydroquinoline derivatives and a process for preparing the same
12/13/2006	EP1730140A1 Opioid receptor antagonists
12/13/2006	EP1730139A2 Pharmaceutical dosage forms and compositions of 5-ht1a receptor antagonists
12/13/2006	EP1730138A1 Epothilone derivatives
12/13/2006	EP1730136A1 N-piperidine derivates as ccr3 modulators
12/13/2006	EP1730134A1 Pyridine inhibitors of erk2 and uses thereof
12/13/2006	EP1730125A2 Substituted hydroxyethylamine aspartyl protease inhibitors
12/13/2006	EP1730124A1 Certain triazole-based compounds, compositions, and uses thereof
12/13/2006	EP1730123A1 Novel amination process
12/13/2006	EP1730122A2 Pyrimidine derivatives and methods of treatment related to the use thereof
12/13/2006	EP1730121A2 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
12/13/2006	EP1730119A1 Imidazole compounds for the treatment of neurodegenerative disorders
12/13/2006	EP1730116A1 4-carbox pyrazole derivates useful as anti-viral agents
12/13/2006	EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
12/13/2006	EP1730112A1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
12/13/2006	EP1729775A2 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
12/13/2006	EP1148880B1 Methods for restoring and/or enhancing accommodation in pseudo phakia
12/13/2006	CN1878770A Novel hypocholesterolemic compounds
12/13/2006	CN1878766A Methods for synthesizing quinolinone compounds
12/13/2006	CN1878761A Arylindenopyridines and arylindenopyridines and their use as adenosine A2a receptor antagonist
12/13/2006	CN1878552A Methods of use of thrombin receptor antagonists
12/13/2006	CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
12/13/2006	CN1289496C Process for producing novel paroxetine hydrochloride anhydrate
12/13/2006	CN1289486C Pyrimidine derivatives as regulating agent of insulin-like growth factor-1 receptor (igf-1)
12/13/2006	CN1289479C 5-cyclo indole compounds as 5-HT receptor ligands
12/13/2006	CN1289472C Hydroxamic acid derivatives and medicinal utilization thereof
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289455C 2-(2,6-dichlorophenyl)-diarylimidazoles
12/13/2006	CN1289087C Quinoline derivatives as neuropeptide y antagonists
12/12/2006	US7148274 Heat and oxidation resistance; photostability for polymers
12/12/2006	US7148252 Therapy or prphylaxis of primary brain cancer or a brain metastasis in a patient, comprising administering benzopyranones derivatives or their pharmaceutically acceptable salts
12/12/2006	US7148249 Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
12/12/2006	US7148242 N-formyl hydroxylamine compounds, compositions and methods of use
12/12/2006	US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006	US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006	US7148224 Pyrazinone derivatives
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	CA2300204C Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
12/12/2006	CA2268314C Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
12/12/2006	CA2245926C 7-phenyl-1,4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
12/12/2006	CA2190851C Palladium catalyzed ring closure of triazolyl tryptamine
12/12/2006	CA2141175C A process for the production of tetrazolyl compounds
12/07/2006	WO2006130075A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129583A1 Pyrazolone derivative
12/07/2006	WO2006129120A2 Benzotriazepinone derivatives
12/07/2006	WO2006129100A1 Novel compounds
12/07/2006	WO2006128692A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006	WO2006128562A1 Use of chromone derivatives
12/07/2006	WO2006057977A3 Cycloalkyl piperidine tachykinin receptor antagonists
12/07/2006	WO2006014012A3 Aromatic compounds
12/07/2006	WO2005112919A8 Self-immolative linkers and drug conjugates
12/07/2006	WO2005112919A2 Self-immolative linkers and drug conjugates
12/07/2006	US20060276650 Pyrazole compounds
12/07/2006	US20060276645 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors
12/07/2006	US20060276520 Rhodanine derivatives and pharmaceutical compositions containing them
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276514 Tyrosine kinase inhibitors
12/07/2006	US20060276512 Fumagillol derivatives and preparing method thereof
12/07/2006	US20060276504 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye
12/07/2006	US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006	US20060276492 Treating human immunodeficiency and hepatitis B infections; high activity, low toxicity
12/07/2006	US20060276485 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276474 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276470 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy
12/07/2006	US20060276454 Monoamine re-uptake inhibitors and methods relating thereto
12/07/2006	US20060276450 Isoquinoline potassium channel inhibitors
12/07/2006	US20060275750 Bioreactive agents
12/07/2006	DE102005025801A1 Verwendung von Chromonderivaten Use of Chromonderivaten
12/07/2006	CA2610695A1 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006	CA2610671A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/06/2006	EP1728785A1 7-[(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-heptanoic acid ester 3,5-dioxo-acetal
12/06/2006	EP1727813A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
12/06/2006	EP1727812A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/06/2006	EP1727811A1 New compounds for the inhibition of angiogenesis and use of thereof
12/06/2006	EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006	EP1727806A1 2,4-diaminopyrimidines and their use for inducing cardiomyogenesis
12/06/2006	EP1727799A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/06/2006	EP1727798A1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
12/06/2006	EP1727794A1 Novel benzyl(idene)-lactam derivatives
12/06/2006	EP1727793A1 Substituted azetidine compounds as cyclooxygenase-1 - cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
12/06/2006	EP1572668A4 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
12/06/2006	EP1368319B1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/06/2006	EP1291343B1 Hydroxyformamidine derivatives and medicines containing the same
12/06/2006	CN1875018A Process for preparing thiazolidinediones
12/06/2006	CN1875015A Benzo [b][1,4] dioxepine derivatives
12/06/2006	CN1874991A Compound capable of binding S1P receptor and pharmaceutical use thereof
12/06/2006	CN1874768A N3 alkylated benzimidazole derivatives as MEK inhibitors
12/06/2006	CN1872851A Compound of alpha ¿C methylene ¿C gamma ¿C butyrolactone, preparation method, and method
12/06/2006	CN1872066A Extractive from roots, halms, leaves of croton, effective content of anti inflammation and ease pain
12/06/2006	CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
12/06/2006	CN1288138C 4,5-disubstituted-1,8-naphthoyl imide compounds and use thereof

1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 694